As reported by RAPS (here), the Pharmaceutical Research and Manufacturers of America (PhRMA) is "harshly criticizing the US Food and Drug Administration's (FDA) research focused on prescription drug advertising and promotion and calling for a clearer vision on how this research protects public health.""FDA has proposed to undertake projects in a variety of disparate topics … [Read more...]
GSK to evaluate Insilico’s AI technology to enhance drug discovery process.
GlaxoSmithKline and Insilico Medicine are partnering to assess how the latter’s artificial intelligence (AI) technology can help in the drug discovery process. … [Read more...]
Evotec completes Aptuit acquisition
German company Evotec has completed the acquisition of US-based Aptuit. … [Read more...]
Seattle Genetics gets FDA priority review for Adcetris in Cutaneous T-Cell Lymphoma
Seattle Genetics reported that the US Food and Drug Administration (FDA) has accepted for filing a supplemental Biologics License Application (BLA) based on data from the phase 3 ALCANZA trial and two phase 2 trials of ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL). … [Read more...]
Mateon’s ovarian cancer treatment CA4P shows favorable results in Focus study
Mateon Therapeutics’ ovarian cancer treatment CA4P in combination with Roche’s bevacizumab (Avastin) has showed favorable results in the scheduled interim analysis of the ongoing phase 2/3 Focus study. … [Read more...]